2008Chinese Journal of Clinical PharmacyRequires access

Pharmacokinetics of self-microemulsifying drug delivery system of simvastatin in Beagle dogs

Wei Wu

Open publisher page 0 citations

Abstract

AIM To evaluate the pharmacokinetics of self-microemulsifying drug delivery system of simvastatin(SV-SMEDDS) in Beagle dogs.METHODS Plasma simvastatin was determined by RP-HPLC with solid-phase extraction using Waters OASIS○ R HLB cartridge.The pharmacokinetics of SV-SMEDDS was evaluated after a single oral dose of 40 mg of simvastain in a two-period crossover experiment design compared with simvastatin suspension(SV-Sus).RESULTS The pharmacokinetics of both SV-SMEDDS and SV-Sus fitted to two-compartment model.The tmax were(0.84±0.26) and(0.99±0.32)h for SV-SMEDDS and SV-Sus respectively,and ρmax were(39.73 ± 9.11) and(28.54±7.76)μg·L-1 respectively.SV-SMEDDS showed a relative bioavailability of 184.84%.CONCLUSION SMEDDS is able to increase the absorbance and bioavailability of simvastatin.

About this research paper

What this paper is about

AIM To evaluate the pharmacokinetics of self-microemulsifying drug delivery system of simvastatin(SV-SMEDDS) in Beagle dogs.METHODS Plasma simvastatin was determined by RP-HPLC with solid-phase extraction using Waters OASIS○ R HLB cartridge.The pharmacokinetics of SV-SMEDDS was evaluated after a single oral dose of 40 mg of simvastain in a two-period crossover experiment design compared with simvastatin suspension(SV-Sus).RESULTS The pharmacokinetics of both SV-SMEDDS and SV-Sus fitted to two-compartment model.The tmax were(0.84±0.26) and(0.99±0.32)h for SV-SMEDDS and SV-Sus respectively,and ρmax were(39.73 ± 9.11) and(28.54±7.76)μg·L-1 respectively.SV-SMEDDS showed a relative bioavailability of 184.84%.CONCLUSION SMEDDS is able to increase the absorbance and bioavailability of simvastatin.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To evaluate the pharmacokinetics of self-microemulsifying drug delivery system of simvastatin(SV-SMEDDS) in Beagle dogs.METHODS Plasma simvastatin was determined by RP-HPLC with solid-phase extraction using Waters OASIS○ R HLB cartridge.The pharmacokinetics of SV-SMEDDS was evaluated after a single oral dose of 40 mg of simvastain in a two-period crossover experiment design compared with simvastatin suspension(SV-Sus).RESULTS The pharmacokinetics of both SV-SMEDDS and SV-Sus fitted to two-compartment model.The tmax were(0.84±0.26) and(0.99±0.32)h for SV-SMEDDS and SV-Sus respectively,and ρmax were(39.73 ± 9.11) and(28.54±7.76)μg·L-1 respectively.SV-SMEDDS showed a relative bioavailability of 184.84%.CONCLUSION SMEDDS is able to increase the absorbance and bioavailability of simvastatin.

Key concepts: Simvastatin, Pharmacokinetics, Beagle, Bioavailability, Pharmacology, Chemistry, Drug delivery, Cmax

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of self-microemulsifying drug delivery system of simvastatin in Beagle dogs — Research Paper | ScholarLens